These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 20186669

  • 1. In vitro osteoclastogenesis on textile chitosan scaffold.
    Heinemann C, Heinemann S, Bernhardt A, Lode A, Worch H, Hanke T.
    Eur Cell Mater; 2010 Feb 26; 19():96-106. PubMed ID: 20186669
    [Abstract] [Full Text] [Related]

  • 2. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
    Chang CC, Tsai YH, Liu Y, Lin SY, Liang YC.
    Rheumatology (Oxford); 2015 Oct 26; 54(10):1913-22. PubMed ID: 25998451
    [Abstract] [Full Text] [Related]

  • 3. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
    Yaroslavskiy BB, Li Y, Ferguson DJ, Kalla SE, Oakley JI, Blair HC.
    J Cell Biochem; 2004 Apr 01; 91(5):962-72. PubMed ID: 15034931
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W, Dou H, Liu X, Sun L, Hou Y.
    Clin Exp Pharmacol Physiol; 2012 Oct 01; 39(10):886-93. PubMed ID: 23013134
    [Abstract] [Full Text] [Related]

  • 5. A 3D in vitro bone organ model using human progenitor cells.
    Papadimitropoulos A, Scherberich A, Güven S, Theilgaard N, Crooijmans HJ, Santini F, Scheffler K, Zallone A, Martin I.
    Eur Cell Mater; 2011 May 15; 21():445-58; discussion 458. PubMed ID: 21604244
    [Abstract] [Full Text] [Related]

  • 6. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA.
    Calcif Tissue Int; 2002 Dec 15; 71(6):539-46. PubMed ID: 12232680
    [Abstract] [Full Text] [Related]

  • 7. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
    Wittrant Y, Theoleyre S, Couillaud S, Dunstan C, Heymann D, Rédini F.
    Exp Cell Res; 2004 Feb 15; 293(2):292-301. PubMed ID: 14729467
    [Abstract] [Full Text] [Related]

  • 8. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC.
    Med Sci Monit; 2018 Apr 26; 24():2569-2577. PubMed ID: 29698379
    [Abstract] [Full Text] [Related]

  • 9. Odontoblast-like MDPC-23 cells function as odontoclasts with RANKL/M-CSF induction.
    Duan X, Yang T, Zhang Y, Wen X, Xue Y, Zhou M.
    Arch Oral Biol; 2013 Mar 26; 58(3):272-8. PubMed ID: 22770625
    [Abstract] [Full Text] [Related]

  • 10. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L, Zhou K, Wang S, Zhang H, Fan N, Li J, Tan X, Hu L, Fan X.
    Cell Physiol Biochem; 2018 Mar 26; 48(5):2123-2133. PubMed ID: 30110702
    [Abstract] [Full Text] [Related]

  • 11. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garćia-Palacios V, Oakley JI, Orchard PJ.
    J Bone Miner Res; 2004 Aug 26; 19(8):1329-38. PubMed ID: 15231021
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of textile chitosan scaffolds for tissue engineering using human bone marrow stromal cells.
    Heinemann C, Heinemann S, Lode A, Bernhardt A, Worch H, Hanke T.
    Biomacromolecules; 2009 May 11; 10(5):1305-10. PubMed ID: 19344120
    [Abstract] [Full Text] [Related]

  • 13. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C, Riggs BL, Khosla S.
    Calcif Tissue Int; 2002 Nov 11; 71(5):437-46. PubMed ID: 12202955
    [Abstract] [Full Text] [Related]

  • 14. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T.
    J Bone Miner Metab; 2000 Nov 11; 18(4):177-84. PubMed ID: 10874596
    [Abstract] [Full Text] [Related]

  • 15. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U, Patel K, Rosol TJ, Ostrowski MC.
    J Bone Miner Res; 2004 Aug 11; 19(8):1339-48. PubMed ID: 15231022
    [Abstract] [Full Text] [Related]

  • 16. Formation of osteoclasts on calcium phosphate bone cements and polystyrene depends on monocyte isolation conditions.
    Bernhardt A, Schumacher M, Gelinsky M.
    Tissue Eng Part C Methods; 2015 Feb 11; 21(2):160-70. PubMed ID: 24919531
    [Abstract] [Full Text] [Related]

  • 17. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 18. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ, Kim KN, Heo SJ, Han SC, Kim J, Ko YJ, Kang HK, Yoo ES.
    Biochem Biophys Res Commun; 2013 May 17; 434(4):892-7. PubMed ID: 23611776
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of differentiation and function of osteoclasts by dimethyl sulfoxide (DMSO).
    Yang C, Madhu V, Thomas C, Yang X, Du X, Dighe AS, Cui Q.
    Cell Tissue Res; 2015 Dec 17; 362(3):577-85. PubMed ID: 26224539
    [Abstract] [Full Text] [Related]

  • 20. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.
    J Bone Miner Res; 2005 Dec 17; 20(12):2224-32. PubMed ID: 16294275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.